Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (LYEL)

Q: What does CUSIP 55083R104 represent in this 13F holders report?

CUSIP 55083R104 is the security identifier for LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share in Q2 2023?

98 institutional investors reported LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 55083R104

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock par value $0.0001 per share
Total 13F shares: 122,233,983
Total 13F value: $388,698,764
Share change: +4,463,560
Put/Call ratio: 1133%
SEC-reported price per share: $3.18
Number of holders: 98
Value change: +$15,244,327
Number of buys: 46
Number of sells: 49
Shares outstanding: 23,360,878

Security key

55083R104

Report period

Q2 2023

Institutions

Top holders

LYEL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Lyell Immunopharma, Inc. SEC filings Lyell Immunopharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 55083R104

Newer quarter: Q3 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GSK plc

Disclosed value leader

GSK plc

Comparable rows

0/15

Latest evidence

31 Mar 2023

3/4/5 13F Highest disclosed value: $68,977,271 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GSK plc has the largest disclosed position value at $68.98M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GSK plc's linked filing trail.

Disclosed position value Top 5

GSK plc $68.98M

MWG Management Ltd. $47.58M

Orland Properties Ltd $35.62M

VANGUARD GROUP INC $30.11M

BlackRock Finance, Inc. $29.12M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GSK plc	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$68,977,271 30,253,189 shares	—	21 Jun 2021
MWG Management Ltd.	13F Company 13F	— denominator unverified	$47,583,104 20,162,332 shares	—	31 Mar 2023
Orland Properties Ltd	13F Company 13F	— denominator unverified	$35,621,767 15,093,969 shares	—	31 Mar 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$30,111,530 12,759,123 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$29,115,634 12,337,133 shares	—	31 Mar 2023
Foresite Capital Management IV, LLC	13F Company 13F	— denominator unverified	$23,600,000 10,000,000 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

122,233,983

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2023 holders

Holder diff

Investor	Q1 2026 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend